Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuhiko Azegami

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Nephrology (Carlton, Vic.)|September 4, 2025
Sodium Polystyrene Sulfonate and Heart Failure Risk: A Comparative Study With Calcium Polystyrene SulfonateTakashin Nakayama, Hidehiro Kaneko, Yuta Suzuki, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 25, 2026
Association of Autosomal Dominant Polycystic Kidney Disease With Incident Aortic Dissection or AneurysmTakashin Nakayama, Hidehiro Kaneko, Yuta Suzuki, et al.
Clinical Kidney Journal|March 18, 2026
Myelodysplastic syndromes and risk of kidney function decline: findings from a nationwide Japanese cohort studyRyunosuke Mitsuno, Hidehiro Kaneko, Yuta Suzuki, et al.
Scientific Reports|February 22, 2023
Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infectionTakashin Nakayama, Tatsuhiko Azegami, Maki Kiso, et al.
European Journal of Clinical Investigation|September 28, 2024
Dose-dependent association between estimated glomerular filtration rate and the subsequent risk of depression: An analysis of a nationwide epidemiological datasetToshiyuki Ko, Hidehiro Kaneko, Yuta Suzuki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 10, 2024
Significance of eGFR and proteinuria for cardiovascular disease in individuals beyond 85 years of ageTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 10, 2025
Lean body mass index and hypertension risk in men: a nationwide epidemiological cohort studyTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2026
Parkinson Disease imposes Risk of Kidney Function DeclineRyunosuke Mitsuno, Hidehiro Kaneko, Yuta Suzuki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 27, 2025
Blood pressure control and treatment status at 1 year after the first health check-up in individuals with observed referral-level blood pressureKaori Kitaoka, Hidehiro Kaneko, Yuta Suzuki, et al.
Diabetes, Obesity & Metabolism|August 19, 2025
Gender differences in the prescription of SGLT2 inhibitors in chronic kidney disease: A real-world database studyTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Nephrology (Carlton, Vic.)|September 4, 2025
Sodium Polystyrene Sulfonate and Heart Failure Risk: A Comparative Study With Calcium Polystyrene SulfonateTakashin Nakayama, Hidehiro Kaneko, Yuta Suzuki, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 25, 2026
Association of Autosomal Dominant Polycystic Kidney Disease With Incident Aortic Dissection or AneurysmTakashin Nakayama, Hidehiro Kaneko, Yuta Suzuki, et al.
Clinical Kidney Journal|March 18, 2026
Myelodysplastic syndromes and risk of kidney function decline: findings from a nationwide Japanese cohort studyRyunosuke Mitsuno, Hidehiro Kaneko, Yuta Suzuki, et al.
Scientific Reports|February 22, 2023
Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infectionTakashin Nakayama, Tatsuhiko Azegami, Maki Kiso, et al.
European Journal of Clinical Investigation|September 28, 2024
Dose-dependent association between estimated glomerular filtration rate and the subsequent risk of depression: An analysis of a nationwide epidemiological datasetToshiyuki Ko, Hidehiro Kaneko, Yuta Suzuki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 10, 2024
Significance of eGFR and proteinuria for cardiovascular disease in individuals beyond 85 years of ageTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 10, 2025
Lean body mass index and hypertension risk in men: a nationwide epidemiological cohort studyTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2026
Parkinson Disease imposes Risk of Kidney Function DeclineRyunosuke Mitsuno, Hidehiro Kaneko, Yuta Suzuki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 27, 2025
Blood pressure control and treatment status at 1 year after the first health check-up in individuals with observed referral-level blood pressureKaori Kitaoka, Hidehiro Kaneko, Yuta Suzuki, et al.
Diabetes, Obesity & Metabolism|August 19, 2025
Gender differences in the prescription of SGLT2 inhibitors in chronic kidney disease: A real-world database studyTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Pageof 10